Lerasan, Shiela Mae .
HRN: 16-91-34 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2025
AMPICILLIN 1GM (VIAL)
05/31/2025
06/03/2025
IV
2 G
Q6
PROM
Checking Initial Appropriateness
05/31/2025
CEFUROXIME 500MG (TAB)
05/31/2025
06/07/2025
PO
500 Mg
BID
PROM
Waiting Final Action